Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2009 | 1 |
2018 | 1 |
2019 | 1 |
2020 | 1 |
2021 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725.
N Engl J Med. 2019.
PMID: 31553834
Clinical Trial.
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease.
Schuppan D, Mäki M, Lundin KEA, Isola J, Friesing-Sosnik T, Taavela J, Popp A, Koskenpato J, Langhorst J, Hovde Ø, Lähdeaho ML, Fusco S, Schumann M, Török HP, Kupcinskas J, Zopf Y, Lohse AW, Scheinin M, Kull K, Biedermann L, Byrnes V, Stallmach A, Jahnsen J, Zeitz J, Mohrbacher R, Greinwald R; CEC-3 Trial Group.
Schuppan D, et al. Among authors: kull k.
N Engl J Med. 2021 Jul 1;385(1):35-45. doi: 10.1056/NEJMoa2032441.
N Engl J Med. 2021.
PMID: 34192430
Free article.
Clinical Trial.
Item in Clipboard
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials.
Rubin DT, Dotan I, DuVall A, Bouhnik Y, Radford-Smith G, Higgins PDR, Mishkin DS, Arrisi P, Scalori A, Oh YS, Tole S, Chai A, Chamberlain-James K, Lacey S, McBride J, Panés J; HIBISCUS Study Group.
Rubin DT, et al.
Lancet Gastroenterol Hepatol. 2022 Jan;7(1):17-27. doi: 10.1016/S2468-1253(21)00338-1. Epub 2021 Nov 17.
Lancet Gastroenterol Hepatol. 2022.
PMID: 34798036
Clinical Trial.
Item in Clipboard
Mycobacterium microti: Not Just a Coincidental Pathogen for Cats.
Peterhans S, Landolt P, Friedel U, Oberhänsli F, Dennler M, Willi B, Senn M, Hinden S, Kull K, Kipar A, Stephan R, Ghielmetti G.
Peterhans S, et al. Among authors: kull k.
Front Vet Sci. 2020 Dec 3;7:590037. doi: 10.3389/fvets.2020.590037. eCollection 2020.
Front Vet Sci. 2020.
PMID: 33344530
Free PMC article.
Item in Clipboard
A Population-Based Surveillance Study on the Epidemiology of Hepatitis C in Estonia.
Mansberg K, Kull K, Salupere R, Prükk T, Margus B, Kariis T, Remmel T, Suurmaa K, Ott K, Jaago K, Šmidt J.
Mansberg K, et al. Among authors: kull k.
Medicina (Kaunas). 2018 Mar 25;54(1):9. doi: 10.3390/medicina54010009.
Medicina (Kaunas). 2018.
PMID: 30344240
Free PMC article.
Item in Clipboard
Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial.
Kruis W, Kiudelis G, Rácz I, Gorelov IA, Pokrotnieks J, Horynski M, Batovsky M, Kykal J, Boehm S, Greinwald R, Mueller R; International Salofalk OD Study Group.
Kruis W, et al.
Gut. 2009 Feb;58(2):233-40. doi: 10.1136/gut.2008.154302. Epub 2008 Oct 2.
Gut. 2009.
PMID: 18832520
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite